| Steroid biosynthesis |
2.56 |
0.00e+0 |
19/20 (95%) |
MSMO1;SQLE;DHCR24;...
|
| Biosynthesis of unsaturated fatty acids |
2.34 |
0.00e+0 |
21/27 (77.78%) |
SCD;FADS1;FADS2;...
|
| PPAR signaling pathway |
2.27 |
0.00e+0 |
66/74 (89.19%) |
SCD;HMGCS1;ACSL3;...
|
| Terpenoid backbone biosynthesis |
2.07 |
2.68e-3 |
18/22 (81.82%) |
HMGCS1;IDI1;FDPS;...
|
| Aldosterone synthesis and secretion |
2.02 |
2.14e-3 |
85/98 (86.73%) |
LDLR;CALML5;ITPR3;...
|
| Glutamatergic synapse |
1.96 |
1.79e-3 |
97/114 (85.09%) |
ITPR3;SLC1A1;SLC38A1;...
|
| Glycerolipid metabolism |
1.95 |
1.53e-3 |
44/61 (72.13%) |
LPIN1;MGLL;PNPLA3;...
|
| Fatty acid elongation |
1.95 |
1.34e-3 |
19/27 (70.37%) |
ELOVL6;ELOVL5;TECR;...
|
| GABAergic synapse |
1.93 |
1.19e-3 |
76/89 (85.39%) |
GABBR1;SLC38A1;GNG11;...
|
| Long-term potentiation |
1.91 |
2.14e-3 |
61/67 (91.04%) |
CALML5;ITPR3;CAMK2B;...
|
| Cardiac muscle contraction |
1.91 |
1.95e-3 |
64/87 (73.56%) |
TPM2;ATP2A2;ATP1A2;...
|
| Insulin secretion |
1.89 |
1.79e-3 |
75/86 (87.21%) |
KCNN4;ITPR3;CAMK2B;...
|
| Regulation of lipolysis in adipocytes |
1.89 |
1.65e-3 |
52/55 (94.55%) |
MGLL;IRS2;NPY1R;...
|
| Adrenergic signaling in cardiomyocytes |
1.89 |
1.53e-3 |
130/150 (86.67%) |
TPM2;CALML5;ATP2A2;...
|
| Dilated cardiomyopathy |
1.87 |
2.14e-3 |
86/96 (89.58%) |
TPM2;ATP2A2;ITGB5;...
|
| Circadian entrainment |
1.85 |
3.35e-3 |
85/97 (87.63%) |
CALML5;ITPR3;CAMK2B;...
|
| Cortisol synthesis and secretion |
1.85 |
3.15e-3 |
58/65 (89.23%) |
LDLR;PBX1;ITPR3;...
|
| Gastric acid secretion |
1.85 |
3.57e-3 |
63/76 (82.89%) |
CALML5;ITPR3;CAMK2B;...
|
| Salivary secretion |
1.83 |
3.95e-3 |
76/93 (81.72%) |
CST3;CALML5;KCNN4;...
|
| Adipocytokine signaling pathway |
1.83 |
3.75e-3 |
64/69 (92.75%) |
ACSL3;IRS2;IRS1;...
|
| GnRH secretion |
1.83 |
3.57e-3 |
60/64 (93.75%) |
KCNN4;ITPR3;GABBR1;...
|
| Fatty acid biosynthesis |
1.80 |
7.31e-3 |
16/18 (88.89%) |
FASN;ACSL3;ACACA;...
|
| Glucagon signaling pathway |
1.79 |
7.46e-3 |
89/107 (83.18%) |
CALML5;PKM;ITPR3;...
|
| Morphine addiction |
1.78 |
7.59e-3 |
80/91 (87.91%) |
GABBR1;GNG11;GNAS;...
|
| cGMP-PKG signaling pathway |
1.77 |
9.43e-3 |
145/167 (86.83%) |
CALML5;ATP2A2;IRS2;...
|
| AMPK signaling pathway |
1.76 |
9.48e-3 |
106/120 (88.33%) |
SCD;FASN;HMGCR;...
|
| Cushing syndrome |
1.75 |
1.27e-2 |
125/155 (80.65%) |
LDLR;PBX1;ITPR3;...
|
| Cholinergic synapse |
1.74 |
1.38e-2 |
99/113 (87.61%) |
ITPR3;CAMK2B;PLCB4;...
|
| Butanoate metabolism |
1.73 |
1.66e-2 |
23/28 (82.14%) |
HMGCS1;ACAT2;AACS
|
| Ovarian steroidogenesis |
1.71 |
1.89e-2 |
41/51 (80.39%) |
LDLR;HSD17B7;GNAS;...
|
| Th1 and Th2 cell differentiation |
-1.59 |
4.03e-2 |
80/92 (86.96%) |
NFKBIE;PRKCQ;CD3G;...
|
| Hematopoietic cell lineage |
-1.60 |
3.87e-2 |
90/99 (90.91%) |
CD33;CD38;CD1A;...
|
| Allograft rejection |
-1.61 |
3.59e-2 |
32/38 (84.21%) |
HLA-DRB1;HLA-DMB;HLA-DRA;...
|
| NF-kappa B signaling pathway |
-1.61 |
3.55e-2 |
90/104 (86.54%) |
RIPK1;SYK;CFLAR;...
|
| Nucleotide excision repair |
-1.65 |
2.50e-2 |
40/47 (85.11%) |
DDB1;POLE2;RFC3;...
|
| Amyotrophic lateral sclerosis |
-1.65 |
2.61e-2 |
267/364 (73.35%) |
NUP85;COX8A;KLC2;...
|
| Rheumatoid arthritis |
-1.66 |
2.52e-2 |
78/93 (83.87%) |
ATP6V1B1;FOS;CCL20;...
|
| Ribosome |
-1.66 |
2.51e-2 |
113/158 (71.52%) |
RPL22;MRPS14;RPS3;...
|
| RNA polymerase |
-1.66 |
2.63e-2 |
23/31 (74.19%) |
POLR3G;POLR2A;POLR2B;...
|
| Staphylococcus aureus infection |
-1.67 |
2.43e-2 |
72/95 (75.79%) |
DEFA4;KRT13;FCGR2C;...
|
| Oxidative phosphorylation |
-1.68 |
2.52e-2 |
93/133 (69.92%) |
ATP6V0A2;COX8A;NDUFC1;...
|
| Parkinson disease |
-1.69 |
2.39e-2 |
176/249 (70.68%) |
COX8A;KLC2;PRKACB;...
|
| Cytosolic DNA-sensing pathway |
-1.71 |
2.08e-2 |
52/63 (82.54%) |
IL18;POLR2F;POLR2H;...
|
| RNA transport |
-1.71 |
1.97e-2 |
128/186 (68.82%) |
SUMO3;EIF2S1;DDX19A;...
|
| Primary immunodeficiency |
-1.74 |
1.19e-2 |
33/38 (86.84%) |
ADA;CD8A;IL7R;...
|
| Pertussis |
-1.75 |
1.28e-2 |
64/76 (84.21%) |
C4BPA;IRF8;CASP7;...
|
| Mismatch repair |
-1.76 |
1.31e-2 |
22/23 (95.65%) |
MLH1;EXO1;RFC3;...
|
| Spliceosome |
-1.78 |
1.26e-2 |
101/150 (67.33%) |
SF3B2;RBMX;HSPA6;...
|
| Leishmaniasis |
-1.80 |
1.11e-2 |
67/77 (87.01%) |
TRAF6;CYBA;NFKBIA;...
|
| Huntington disease |
-1.81 |
9.24e-3 |
233/306 (76.14%) |
COX8A;KLC2;DNAH9;...
|
| Protein export |
-1.83 |
9.24e-3 |
17/23 (73.91%) |
SRP54;SPCS3;SEC61B;...
|
| Asthma |
-1.83 |
1.06e-2 |
25/31 (80.65%) |
FCER1G;HLA-DRB1;HLA-DMB;...
|
| Legionellosis |
-1.84 |
1.08e-2 |
51/57 (89.47%) |
NFKBIA;HSPD1;TLR2;...
|
| Prion disease |
-1.87 |
7.39e-3 |
209/273 (76.56%) |
HSPA6;COX8A;KLC2;...
|
| Intestinal immune network for IgA production |
-1.91 |
6.93e-3 |
38/48 (79.17%) |
HLA-DPB1;HLA-DOA;CD28;...
|
| Systemic lupus erythematosus |
-2.00 |
0.00e+0 |
45/135 (33.33%) |
FCGR3B;CD86;SNRPD3;...
|
| Proteasome |
-2.16 |
0.00e+0 |
44/46 (95.65%) |
PSMA5;PSMB6;PSMD7;...
|
| Ribosome biogenesis in eukaryotes |
-2.19 |
0.00e+0 |
52/108 (48.15%) |
GNL2;POP4;NOP10;...
|
